The U.S. government is likely to end the pause if the panel says the vaccine’s benefits outweigh the potential risk.The U.S. government is likely to end the pause if the panel says the vaccine’s benefits outweigh the potential risk.internal-essential, Blood Clots, Vaccination and Immunization, Coronavirus (2019-nCoV), Labeling and Labels (Product), Advisory Committee on Immunization Practices, Centers for Disease Control and PreventionRead More
